Powered by Google Google ÜbersetzerGoogle Übersetzer
Originaltext
Diese Übersetzung bewerten
Mit deinem Feedback können wir Google Übersetzer weiter verbessern
Latest Press Releases
View all
TimeHeadline
23m agoNayax to Report 2026 Q1 Earnings on May 12, 2026
50m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
1h agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
1h agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
1h agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
Eterna Therapeutics Inc logo

Eterna Therapeutics Inc

About

Eterna Therapeutics Inc (NASDAQ:ERNA) — investor relations, events, news, and company updates on 6ix.

Latest News

Feb 20 2026
Ernexa Therapeutics to Participate in Virtual Investor Closing Bell Series
Feb 6 2026
Ernexa Therapeutics Announces Pricing of $10.5 Million Public Offering
Feb 3 2026
Ernexa Therapeutics Participates in Virtual Investor “What This Means” Segment Highlighting Recent Successful Pre-IND Meeting with U.S. FDA
Jan 27 2026
Ernexa Therapeutics Selected as One of Only Ten Global Companies for Prestigious JETRO Japan Entry Acceleration Program
Jan 6 2026
Ernexa Therapeutics Announces Successful Pre-IND FDA Meeting and Continues Progress Toward First-in-Human Trial in Ovarian Cancer

Financials

Revenue
$1 K
Market Cap
$6.11 M
EPS
-2.24

Community Chat

Ask AI

6ix6ixAIEvents